10x Genomics (TXG) Treasury Shares (2018 - 2026)

10x Genomics (TXG) has 9 years of Treasury Shares data on file, last reported at $8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 4.62% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (up 4.62% YoY), and the FY2025 full-year result was $7.8 million, up 20.53% from the prior year.
• Treasury Shares improved to $8.0 million in Q1 2026, from $7.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $9.2 million in Q2 2025 to a low of $1.6 million in Q1 2022.
• A 5-year average of $6.2 million and a median of $6.4 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares soared 349.55% in 2022 and fell 8.6% in 2023, its largest moves.
• Tracing TXG's Treasury Shares over 5 years: stood at $5.8 million in 2022, then fell by 8.6% to $5.3 million in 2023, then grew by 21.73% to $6.5 million in 2024, then rose by 20.53% to $7.8 million in 2025, then increased by 1.92% to $8.0 million in 2026.
• Business Quant data shows TXG's Treasury Shares at $8.0 million in Q1 2026, $7.8 million in Q4 2025, and $8.5 million in Q3 2025.